Alexandre Fauché

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies

Alexandre Fauché, Émilie Presles, Olivier Sanchez et al. · Journal of Thrombosis and Haemostasis · 2022 · 24 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez et al. · EClinicalMedicine · 2023 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Risk stratification for predicting recurrent venous thromboembolism after discontinuation of anticoagulation: a <i>post hoc</i> analysis of a French prospective multicentre study

Raphaël Le Mao, Charles Orione, Claire de Moreuil et al. · European Respiratory Journal · 2022 · 11 citations · Full text

Medicine, Hematology, Epidemiology +16